UBS Group’s Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex ACIC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,958
Closed -$8K 10670
2021
Q2
$8K Buy
4,958
+4,235
+586% +$6.12K ﹤0.01% 8292
2021
Q1
$1K Buy
+723
New +$1.84K ﹤0.01% 8887

UBS Group's ACIC.WS Position: Q3 2021 in Review

UBS Group sold out of Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex (ACIC.WS) in Q3 2021, closing a stake of 4,958 shares — an estimated $8K sold.

UBS Group first reported a position in ACIC.WS in Q1 2021 and held it in 2 quarters. The position peaked at $8K in Q2 2021. 0 funds tracked by Wall St. Rank hold ACIC.WS as of Q3 2021.

  • UBS Group reported no remaining Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 4,958 Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex shares in Q3 2021, an estimated $8K.
  • UBS Group first reported a position in Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex in Q1 2021 and held it in 2 quarters.
  • UBS Group's Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex position peaked at $8K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.